CDG Therapeutics' intellectual property includes seven issued patents on the founders' core technology and improvements:
patent #7084105 issued August 1, 2006
patent #7301010 issued November 27, 2007
patent #7338766 issued March 4, 2008
patent #7381701 issued June 3, 2008
patent #7491394 issued February 17, 2009
patent #7511117 issued March 31, 2009
patent #7556810 issued July 7, 2009Additionally, CDG Therapeutics' patent portfolio includes numerous international patent applications on the founders’ core technology and improvements. CDG Therapeutics continues to file new utility and provisional patent applications as our research advances.
The company possesses an exclusive worldwide license to commercialize the founders’ discoveries. These exclusive rights were granted to CDG by the University of Illinois in exchange for royalties on any commercial products to emerge from the company’s efforts, as well as an equity stake held by the University. The royalty rates and equity stake granted to the University by CDG are consistent with those between other development stage companies and their respective university partners.
